SEC Form 4 · accession 0001209191-15-003566
Ignyta, Inc. · RXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adrian Senderowicz
Officer — Chief Medical Officer
Period of report
Jan 8, 2015
Accepted (ET)
Jan 9, 2015 · 7:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557421
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.58 | Jan 8, 2015 | A | 8,400 | A | — | Jan 7, 2025 | Common Stock | 8,400 | 8,400 | D |
Explanation of responses
- F1The option is exercisable as it vests. 25% of the total number of shares subject to the option vest on January 8, 2016, and 1/48th of the total number of shares subject to the option vest monthly thereafter.